28.09.2022Aura Biosciences Announces First Patient Dosed in Phase 1 Study Evaluating Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

Press Release
12.09.2022AviadoBio selected by Fierce Biotech as a ‘Fierce 15’ 2022 winner

Press Release
12.09.2022Fierce Biotech Names Amphista Therapeutics as One of its “Fierce 15” Biotech Companies of 2022

Press Release
04.08.2022F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

Press Release
04.08.2022GILEAD SCIENCES TO ACQUIRE MIROBIO

Press Release
01.07.2022Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

Press Release
28.06.2022Wondr Medical raise £12 million in Seed round to accelerate global collaboration across the medical community

Press Release
14.06.2022PROXIMIE RAISES $80 MILLION IN SERIES C FUNDING TO ACCELERATE PRODUCT EXPANSION OF FULL-SERVICE CONNECTED SURGICAL PLATFORM

Press Release
26.05.2022Aura Biosciences Announces Publication of Preclinical Data of the Combination of VDCs with Immune Checkpoint Inhibitors at the 2022 ASCO Annual Meeting

Press Release
25.05.2022Advent Life Sciences Announces Growth of Investment Team with Three Senior Appointments

Press Release